BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28407802)

  • 21. Intra-operative sentinel lymph node identification using a novel receptor-binding agent (technetium-99m neomannosyl human serum albumin, 99mTc-MSA) in stage I non-small cell lung cancer.
    Kim S; Kim HK; Kang DY; Jeong JM; Choi YH
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1450-6. PubMed ID: 20353895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
    Park HK; Jeon K; Koh WJ; Suh GY; Kim H; Kwon OJ; Chung MP; Lee KS; Shim YM; Han J; Um SW
    Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinicopathological features associated with skip N2 metastases in patients with clinical stage IA non-small-cell lung cancer.
    Gorai A; Sakao Y; Kuroda H; Uehara H; Mun M; Ishikawa Y; Nakagawa K; Masuda M; Okumura S
    Eur J Cardiothorac Surg; 2015 Apr; 47(4):653-8. PubMed ID: 24957260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
    Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
    J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Completeness of lung cancer surgery: is mediastinal dissection common practice?
    Verhagen AF; Schoenmakers MC; Barendregt W; Smit H; van Boven WJ; Looijen M; van der Heijden EH; van Swieten HA
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):834-8. PubMed ID: 22290900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reasonable extent of lymph node dissection in intentional segmentectomy for small-sized peripheral non-small-cell lung cancer: from the clinicopathological findings of patients who underwent lobectomy with systematic lymph node dissection.
    Matsumura Y; Hishida T; Yoshida J; Aokage K; Ishii G; Nagai K
    J Thorac Oncol; 2012 Nov; 7(11):1691-7. PubMed ID: 23059781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prediction model for N2 disease in T1 non-small cell lung cancer.
    Zhang Y; Sun Y; Xiang J; Zhang Y; Hu H; Chen H
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1360-4. PubMed ID: 22819364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection.
    Haruki T; Aokage K; Miyoshi T; Hishida T; Ishii G; Yoshida J; Tsuboi M; Nakamura H; Nagai K
    J Thorac Oncol; 2015 Jun; 10(6):930-6. PubMed ID: 26001143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Video-assisted vs open mediastinal lymphadenectomy for Stage I non-small-cell lung cancer: results of a prospective randomized trial.
    Palade E; Passlick B; Osei-Agyemang T; Günter J; Wiesemann S
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):244-9; discussion 249. PubMed ID: 23295451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and prognostic factors of node-negative non-small cell lung cancer larger than 5 cm.
    Cho S; Kim K; Jheon S
    Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):448-454. PubMed ID: 28575399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors of lymph node metastasis in patients with non-small cell lung cancer ≤ 2 cm in size: A monocentric population-based analysis.
    Yu X; Li Y; Shi C; Han B
    Thorac Cancer; 2018 Jan; 9(1):3-9. PubMed ID: 29034994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score.
    Ishiguro F; Matsuo K; Fukui T; Mori S; Hatooka S; Mitsudomi T
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):1001-6. PubMed ID: 19733863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer.
    Zhang YK; Chai ZD; Tan LL; Wang ZY; Chen ZJ; Le HB; Zhu WY
    World J Surg Oncol; 2017 Mar; 15(1):64. PubMed ID: 28302176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is tumor diameter a risk factor for occult N1 metastasis in patients with peripheral non-small cell lung cancer which is smaller than 3 cm?
    Sayan M; Celik A; Kankoc A; Akarsu I; Aslan MT; Kurtoglu A; Ahmedova G; Tastepe AI
    Updates Surg; 2023 Dec; 75(8):2335-2342. PubMed ID: 37382803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non-Small Cell Lung Cancer.
    Smeltzer MP; Faris N; Yu X; Ramirez RA; Ramirez LE; Wang CG; Adair C; Berry A; Osarogiagbon RU
    Ann Thorac Surg; 2016 Aug; 102(2):448-53. PubMed ID: 27266421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
    Higashi K; Ito K; Hiramatsu Y; Ishikawa T; Sakuma T; Matsunari I; Kuga G; Miura K; Higuchi T; Tonami H; Yamamoto I
    J Nucl Med; 2005 Feb; 46(2):267-73. PubMed ID: 15695786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preliminary comparison research of thoracoscopy and thoracotomy lobectomy for clinical N0 and post-operatively pathological N2 non-small cell lung cancer].
    Li FW; Jiang GC; Li Y; Bu L; Yang F; Li JF; Zhao H; Liu YG; Zhou ZL; Liu J; Wang J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 43(6):861-5. PubMed ID: 22178835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.